Sanofi makes hostile offer for Genzyme
October 4, 2010Manufacturing and Production, Research and Development, Sales and Marketing Genzyme, Sanofi-Aventis
Sanofi-Aventis’ courtship dance around Genzyme has turned more aggressive with an offer – made over the heads of Genzyme’s board …
Managing the Franchise
October 4, 2010Sales and Marketing branding, marketing, product portfolio
Commercial managers who are responsible for a number of brands face a constant dilemma in choosing where across the franchise …
Mitsui boosts contract manufacturing business
October 4, 2010Manufacturing and Production API, Arch Pharmalabs, India, Mitsui
Mitsui & Co has taken a 5% stake in Indian active pharmaceutical ingredients manufacturer Arch Pharmalabs in a $13 million …
Further expansion for Doctors.net.uk pharma team
October 4, 2010Sales and Marketing Doctors.net.uk, GPs, communications, doctors, pharma marketing
New hires to support and drive rapid growth
GSK drops herpes vaccine
October 4, 2010Research and Development, Sales and Marketing GlaxoSmithKline, Simplirix, herpes, sexual health
Poor phase III results have forced GlaxoSmithKline to halt development of its Simplirix vaccine for women with genital herpes. The …
David Gallagher to head up IPHA
October 4, 2010Sales and Marketing IPHA, appointment, sales and marketing
Pfizer Healthcare Ireland’s managing director David Gallagher has been elected president of the Irish Pharmaceutical Healthcare Association (IPHA). David has …
Talking R&D: US regulatory guidelines
October 4, 2010Manufacturing and Production, Research and Development Talking R&D, eCTD submissions
Recent speculation surrounding current diabetes drugs and their long term effect on cardiovascular health has heads spinning in the pharmaceutical …
Zydus Nycomed’s API plant to start production soon
October 4, 2010Manufacturing and Production API, India, Nycomed, Zydus Cadila
Nycomed has said that construction and validation of an active pharmaceutical ingredient manufacturing unit at its plant in Navi Mumbai, …
AZ-BMS diabetes drug impresses in phase III trials
October 1, 2010Research and Development, Sales and Marketing AstraZeneca, BMS, dapagliflozin, diabetes
AstraZeneca and Bristol Myers Squibb’s potential first-in-class diabetes drug dapagliflozin has shown strong results in a late stage trial. It …
FDA unveils new trial data rules
October 1, 2010Research and Development FDA, clinical trials, pharmacovigilance
The FDA has clarified its rules on what safety information must be reported during clinical trials of investigational drugs and …
BMS poaches AZ’s head of global medical affairs
October 1, 2010Research and Development, Sales and Marketing BMS, appointment, research and development, sales and marketing
Bristol-Myers Squibb has appointed Dr Rick Lones as executive medical director in the UK. He joins BMS from AstraZeneca, where …
New digital agency Intensity launched
October 1, 2010Medical Communications Creston, Intensity, OnMedica, Pan, Red Door
Medical communications group Creston has launched a new digital specialist agency called Intensity Digital. The start-up agency aims to serve …
J&J chief admits mistakes at Congressional hearing
October 1, 2010Sales and Marketing Johnson & Johnson, manufacturing compliance, recalls
Johnson & Johnson chief executive William Weldon admitted yesterday that his company had failed to maintain quality standards and mishandled …
Sanofi signs $2.2bn CRO deal
October 1, 2010Research and Development CRO, Covance, Sanofi-Aventis
Sanofi-Aventis has signed a major deal to contract out a wide range of drug development and laboratory services as part …
The Food and Drug Administration (FDA)
October 1, 2010FDA, Food and Drug Administration
The current incarnation of the Food and Drug Administration (FDA) was established in 1930, but the US regulator’s modern functions …
National Institute for health and Clinical Excellence (NICE)
October 1, 2010NICE, National Institute for health and Clinical Excellence
The National Institute for health and Clinical Excellence (NICE) is a UK cost-effectiveness body that assesses a drug’s cost against …
Doctors express serious doubts about health reforms
October 1, 2010Sales and Marketing BMA, NHS, healthcare reform, reform
The government’s plans for radical reform of the NHS has come under attack from doctors’ association the BMA, which says …
GPs urge more patient ‘self care’ for minor ailments
September 30, 2010Medical Communications Doctors.net.uk, OTC, doctors, pharma, simon grime
Research by Doctors.net.uk, on behalf of OTC Bulletin, has revealed that nine out of ten general practitioners in the UK …
Caelyx rights to revert back to Janssen
September 30, 2010Sales and Marketing Caelyx, Janssen, Merck
Marketing rights for cancer treatment Caeylx outside the US will be returned to Janssen from Merck after a licensing deal …
New Herceptin data sways NICE
September 30, 2010Sales and Marketing Herceptin, NICE, Roche
NICE is now minded to approve Roche’s Herceptin for patients with metastatic gastric cancer after receiving new efficacy data from …
Latest content
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board
